Zymeworks, Inc. (ZYME)
28.87
+0.02
(+0.07%)
USD |
NASDAQ |
Oct 28, 16:00
28.87
0.00 (0.00%)
After-Hours: 20:00
Zymeworks Price to Book Value : 25.85 for Oct. 28, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 27, 2026 | 25.83 |
| October 26, 2026 | 25.40 |
| October 23, 2026 | 25.27 |
| October 22, 2026 | 25.47 |
| October 21, 2026 | 25.17 |
| October 20, 2026 | 24.10 |
| October 19, 2026 | 22.87 |
| October 16, 2026 | 22.41 |
| October 15, 2026 | 23.06 |
| October 14, 2026 | 22.18 |
| October 13, 2026 | 22.45 |
| October 12, 2026 | 22.68 |
| October 09, 2026 | 23.09 |
| October 08, 2026 | 22.62 |
| October 07, 2026 | 23.76 |
| October 06, 2026 | 22.97 |
| October 05, 2026 | 23.47 |
| October 02, 2026 | 22.52 |
| October 01, 2026 | 23.24 |
| September 30, 2026 | 23.72 |
| September 29, 2026 | 24.35 |
| September 28, 2026 | 24.28 |
| September 25, 2026 | 23.75 |
| September 24, 2026 | 24.01 |
| September 23, 2026 | 24.62 |
| Date | Value |
|---|---|
| September 22, 2026 | 24.68 |
| September 21, 2026 | 24.01 |
| September 18, 2026 | 23.79 |
| September 17, 2026 | 24.61 |
| September 16, 2026 | 23.50 |
| September 15, 2026 | 23.33 |
| September 14, 2026 | 24.04 |
| September 11, 2026 | 23.50 |
| September 10, 2026 | 23.67 |
| September 09, 2026 | 24.31 |
| September 08, 2026 | 25.17 |
| September 04, 2026 | 26.14 |
| September 03, 2026 | 26.77 |
| September 02, 2026 | 27.80 |
| September 01, 2026 | 26.57 |
| August 31, 2026 | 26.33 |
| August 28, 2026 | 25.31 |
| August 27, 2026 | 25.98 |
| August 26, 2026 | 26.24 |
| August 25, 2026 | 24.60 |
| August 24, 2026 | 25.76 |
| August 21, 2026 | 25.67 |
| August 20, 2026 | 23.79 |
| August 19, 2026 | 24.36 |
| August 18, 2026 | 23.34 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| AbbVie, Inc. | -- |
| Aprea Therapeutics, Inc. | 0.1733 |
| ACADIA Pharmaceuticals, Inc. | 2.675 |
| Alnylam Pharmaceuticals, Inc. | 22.96 |
| Anika Therapeutics, Inc. | 2.097 |
Price to Book Value Related Metrics
| PS Ratio | 58.09 |
| PEG Ratio | -0.1358 |
| Price | 28.87 |
| Earnings Yield | -6.98% |
| Market Cap | 2.078B |
| PEGY Ratio | -0.1358 |